Technical Analysis for VACC - Vaccitech plc

Grade Last Price % Change Price Change
C 14.5 -3.33% -0.50
VACC closed down 3.33 percent on Wednesday, July 28, 2021, on 11 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical VACC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
50 DMA Resistance Bearish -3.33%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.33%
Narrow Range Bar Range Contraction -3.33%
Inside Day Range Contraction -3.33%
Oversold Stochastic Weakness -3.33%
50 DMA Resistance Bearish -3.33%
Older End-of-Day Signals for VACC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance about 17 hours ago
20 DMA Resistance about 17 hours ago
10 DMA Resistance about 17 hours ago
Rose Above Previous Day's High about 19 hours ago
Rose Above 10 DMA about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Vaccitech plc Description

Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing AZD1222, a COVID-19 vaccine. Vaccitech plc was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc on March 31, 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, United Kingdom.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Infectious Diseases Cancers Prostate Cancer Non Small Cell Lung Cancer Vaccine Vaccination Medical Research Treatment Of Non Small Cell Lung Cancer Shingles Immunotherapeutics Treatment Of Prostate Cancer Vaccines Prevention Of Infectious Diseases

Is VACC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.99
52 Week Low 12.25
Average Volume 35,985
200-Day Moving Average 0.00
50-Day Moving Average 15.06
20-Day Moving Average 15.31
10-Day Moving Average 15.12
Average True Range 0.84
ADX 11.55
+DI 19.81
-DI 18.98
Chandelier Exit (Long, 3 ATRs) 15.41
Chandelier Exit (Short, 3 ATRs) 16.80
Upper Bollinger Bands 16.58
Lower Bollinger Band 14.05
Percent B (%b) 0.18
BandWidth 16.48
MACD Line -0.08
MACD Signal Line 0.04
MACD Histogram -0.1166
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.76
Resistance 3 (R3) 15.90 15.62 15.55
Resistance 2 (R2) 15.62 15.30 15.55 15.48
Resistance 1 (R1) 15.06 15.10 14.92 14.92 15.41
Pivot Point 14.78 14.78 14.71 14.71 14.78
Support 1 (S1) 14.22 14.46 14.08 14.08 13.59
Support 2 (S2) 13.94 14.26 13.87 13.52
Support 3 (S3) 13.38 13.94 13.45
Support 4 (S4) 13.24